- Home
- BH vs AXGN Comparison
BH vs AXGN Comparison
Compare BH & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BH
- AXGN
- Stock Information
- Founded
- BH 1934
- AXGN N/A
- Country
- BH United States
- AXGN United States
- Employees
- BH N/A
- AXGN N/A
- Industry
- BH Restaurants
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BH Consumer Discretionary
- AXGN Health Care
- Exchange
- BH Nasdaq
- AXGN Nasdaq
- Market Cap
- BH 561.5M
- AXGN 584.7M
- IPO Year
- BH N/A
- AXGN N/A
- Fundamental
- Price
- BH $207.89
- AXGN $13.34
- Analyst Decision
- BH
- AXGN Strong Buy
- Analyst Count
- BH 0
- AXGN 4
- Target Price
- BH N/A
- AXGN $15.00
- AVG Volume (30 Days)
- BH 6.7K
- AXGN 416.3K
- Earning Date
- BH 11-08-2024
- AXGN 11-07-2024
- Dividend Yield
- BH N/A
- AXGN N/A
- EPS Growth
- BH 158.68
- AXGN N/A
- EPS
- BH 180.85
- AXGN N/A
- Revenue
- BH $361,664,000.00
- AXGN $180,855,000.00
- Revenue This Year
- BH N/A
- AXGN $18.91
- Revenue Next Year
- BH N/A
- AXGN $12.93
- P/E Ratio
- BH $12.76
- AXGN N/A
- Revenue Growth
- BH N/A
- AXGN 18.79
- 52 Week Low
- BH $143.40
- AXGN $5.55
- 52 Week High
- BH $219.00
- AXGN $15.90
- Technical
- Relative Strength Index (RSI)
- BH 72.33
- AXGN 49.78
- Support Level
- BH $200.01
- AXGN $12.37
- Resistance Level
- BH $213.95
- AXGN $13.01
- Average True Range (ATR)
- BH 9.83
- AXGN 0.97
- MACD
- BH 2.27
- AXGN -0.04
- Stochastic Oscillator
- BH 83.73
- AXGN 41.69
About BH Biglari Holdings Inc. Class B
Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations, and Maxim. The majority of revenue is derived from the Restaurant Operations segment. The Restaurant Operations segment includes Steak n Shake and Western Sizzlin Restaurant businesses.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.